Antisense Therapeutics Limited
Antisense Therapeutics is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases.
Microbiology Product Areas
Pharmaceutical | ||
| Assay Development | Show all suppliers | |
Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!
LATEST MICROBIOLOGY NEWS
- BIPEA - Proficiency Testing Experts Since the 1990s
- Rapid Testing of Cosmetics in Full Compliance With ISO 17516
- Measurlabs’ Solutions for PFAS Analysis by EU and US Regulations
- Water System Qualification and Re-Qualifications, Considerations for Microbial Identification
- PharmaLab 2024 - Call for Papers - Share your Knowledge and Experience on RMM/AMM
- Microbiome Insights Launches Long-Read Sequencing Services for 16S rRNA Gene and Metagenomics
- A New Challenger Enters the Rapid Total Viable Count Field
- Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID 2024
- Sino Biological Finalizes the Acquisition of SignalChem Biotech
- EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership
MICROBIOLOGY EVENTS
- British Society For Microbial Technology 39th Annual Microbiology Conference
- Neogen® New and Emerging Methods in Microbiology Workshop
- ASGCT 27th Annual Meeting
- Modern Methods for Endotoxins and Pyrogens Testing
- ATMPs and Microbiological Related Issues
- Implementing a Robust Viable EM Program
- Cleanroom Technology Conference 2024
- Best Practices in Environmental Monitoring
- Food Safety Trends Conference
- European Microbiology Conference and Workshop 2024